Drug Receipts is a collection of digital artworks (NFTs) running on the Ethereum network. This website is only an interface allowing participants to exchange digital collectibles. Users are entirely responsible for the safety and management of their own private Ethereum wallets and validating all transactions and contracts generated by this website before approval. Furthermore, as the Drug Receipts smart contract runs on the Ethereum network, there is no ability to undo, reverse, or restore any transactions.
This website and its connected services are provided “as is” and “as available” without warranty of any kind. By using this website you are accepting sole responsibility for any and all transactions involving Drug Receipts digital collectibles.
iii. Commercial Use. Subject to your continued compliance with these Terms, Drug Receipts General Services Inc grants you an unlimited, worldwide license to use, copy, and display the purchased Art for the purpose of creating derivative works based upon the Art (“Commercial Use”). Examples of such Commercial Use would e.g. be the use of the Art to produce and sell merchandise products (T-Shirts etc.) displaying copies of the Art. For the sake of clarity, nothing in this Section will be deemed to restrict you from (i) owning or operating a marketplace that permits the use and sale of Drug Receipts NFTs generally, provided that the marketplace cryptographically verifies each Drug Receipts NFT owner’s rights to display the Art for their Drug Receipts NFT to ensure that only the actual owner can display the Art; (ii) owning or operating a third party website or application that permits the inclusion, involvement, or participation of Drug Receipts NFTs generally, provided that the third party website or application cryptographically verifies each Drug Receipts NFT owner’s rights to display the Art for theirDrug Receipts NFT to ensure that only the actual owner can display the Art, and provided that the Art is no longer visible once the owner of the Purchased Drug Receipts NFT leaves the website/application; or (iii) earning revenue from any of the foregoing